Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

ScRNAseq of four syngeneic human melanoma cell lines (two replicate per cell line) to study mechanisms of resistance to the BRAF inhibitor vemurafenib


ABSTRACT: Three cell lines were derived from the A375 human melanoma (harbouring the BRAF v600e mutation; ATCC) after treatment with vemurafenib during a period of 4-5 weeks in the absence (MAPKi-resist Rep1/Rep2) or presence of the fatty acid oxidation inhibitors etomoxir (Etomoxir Rep1/Rep2) or ranolazine (Ranolazine Rep1/Rep2).

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo sapiens

SUBMITTER: Camille Stephan-Otto Attolini 

PROVIDER: E-MTAB-12412 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2016-06-30 | GSE75588 | GEO
2023-12-06 | GSE210212 | GEO
2009-01-31 | E-GEOD-13254 | biostudies-arrayexpress
2010-05-06 | E-GEOD-13256 | biostudies-arrayexpress
2021-02-23 | E-MTAB-10050 | biostudies-arrayexpress
2025-01-31 | E-MTAB-14249 | biostudies-arrayexpress
2025-12-30 | E-MTAB-16187 | biostudies-arrayexpress
2023-11-20 | E-MTAB-13205 | biostudies-arrayexpress
2026-06-16 | E-MTAB-16924 | biostudies-arrayexpress
2023-02-02 | PXD035489 | Pride